FDA news: Colorectal, prostate cancer treatments receive fast track designations
The FDA announced several regulatory actions the past few weeks. Here is an overview of decisions that may be relevant to your practice.
United States Mindy Valcarcel T Cdx Tempus Lantheus Holdings Office Of Orphan Products Development Bristol Myers Squibb
Source: healio.com